MAPT and supranuclear palsy, progressive, 1: Taking into account all these data, we studied the tau load and distribution among the PSP phenotypes of a series of 34 cases who were retrospectively classified following the criteria established by Respondek in 2014 and also according with phenotypes resulting from the new MDS-PSP criteria, at 3 years of disease progression, at 6 years and at the final visit before death.